Loading...
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
Hamdi, Abdelrahman Yaseen, Muhammad Ewesa, Wafaa A. Bhat, Mashooq Ahmad Ziedan, Noha El-Shafey, Hamed W. Mohamed, Ahmed A. B. Elnagar, Mohamed R. Haikalh, Abdullah Othmana, Dina I. A.
Hamdi, Abdelrahman
Yaseen, Muhammad
Ewesa, Wafaa A.
Bhat, Mashooq Ahmad
Ziedan, Noha
El-Shafey, Hamed W.
Mohamed, Ahmed A. B.
Elnagar, Mohamed R.
Haikalh, Abdullah
Othmana, Dina I. A.
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2023-07-20
Submitted Date
Collections
Files
Loading...
Article - VoR
Adobe PDF, 3.79 MB
Other Titles
Abstract
This research study describes the development of new small molecules based on 2,4-thiazolidinedione (2,4-TZD) and their aldose reductase (AR) inhibitory activities. The synthesis of 17 new derivatives of 2,4-TZDs hybrids was feasible by incorporating two known bioactive scaffolds, benzothiazole heterocycle, and nitro phenacyl moiety. The most active hybrid (8b) was found to inhibit AR in a non-competitive manner (0.16 µM), as confirmed by kinetic studies and molecular docking simulations. Furthermore, the in vivo experiments demonstrated that compound 8b had a significant hypoglycaemic effect in mice with hyperglycaemia induced by streptozotocin. Fifty milligrams per kilogram dose of 8b produced a marked decrease in blood glucose concentration, and a lower dose of 5 mg/kg demonstrated a noticeable antihyperglycaemic effect. These outcomes suggested that compound 8b may be used as a promising therapeutic agent for the treatment of diabetic complications.
Citation
Hamdi, A., Yaseen, M., Ewesa, W. A., Bhat, M. A., Ziedan, N., El-Shafey, H. W., Mohamed, A. A. B., Elnagar, M. R., Haikalh, A., Othmana, D. I. A., Elgazari, A. A., Abusabaaj, A. H. A., Abdelrahman, K. S., Soltan, O. M., & Elbadawi, M. M. (2023). Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. Journal of Enzyme Inhibition and Medicinal Chemistry, 38(1), Article-number: 2231170. https://doi.org/10.1080/14756366.2023.2231170
Publisher
Taylor & Francis
Journal
Journal of Enzyme Inhibition and Medicinal Chemistry
Research Unit
DOI
10.1080/14756366.2023.2231170
PubMed ID
PubMed Central ID
Type
Article
Language
Description
Series/Report no.
ISSN
1475-6366
EISSN
1475-6374